erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the
.
check out original content and videos published every day to help you learn about the issues that mean the most to you.
.
did you know?
unleash the power of sip - invest in mutual funds
.
.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
february 2009 (19)
. it causes stroke and dementia as well as mood disturbance. svd increases with age but is accelerated by hypertension and diabetes.